We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,352.00
Bid: 11,348.00
Ask: 11,350.00
Change: 84.00 (0.75%)
Spread: 2.00 (0.018%)
Open: 11,288.00
High: 11,412.00
Low: 11,288.00
Prev. Close: 11,268.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

20 Apr 2021 15:12

EU regulator finds possible link between J&J COVID-19 vaccine and blood clots

April 20 (Reuters) - Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who had received the shot in the United States, the watchdog said on Tuesday.(Reporting b...

Read more
20 Apr 2021 14:23

UPDATE 2-Switzerland 'unfortunately' still awaiting AstraZeneca COVID-19 vaccine data - official

* Alpine nation has approved 3 COVID-19 vaccines, so far* Swiss expect 8 mln Q2 vaccine doses, despite Moderna hiccups (Adds detail in 6th paragraph about possible recommendation for AstraZeneca vaccine, following rare blood clots)By John MillerZU...

Read more
20 Apr 2021 14:23

UPDATE 1-Switzerland 'unfortunately' still awaiting AstraZeneca COVID-19 vaccine data - official

(Adds details, background)By John MillerZURICH, April 20 (Reuters) - Switzerland's drug regulator is still awaiting data needed to consider AstraZeneca's COVID-19 vaccine candidate for approval, a Swissmedic official said on Tuesday, adding the in...

Read more
20 Apr 2021 13:42

Switzerland 'unfortunately' still awaiting AstraZeneca COVID-19 vaccine data - official

ZURICH, April 20 (Reuters) - Switzerland's drug regulator is still awaiting data needed to consider AstraZeneca's COVID-19 vaccine candidate for approval, a Swissmedic official said on Tuesday, adding the information "unfortunately" has yet to be...

Read more
20 Apr 2021 13:02

Swedes under 65 to be given alternative to AstraZeneca vaccine for second dose

STOCKHOLM, April 20 (Reuters) - Swedes under 65 vaccinated with one shot of the AstraZeneca COVID-19 vaccine will be given a different vaccine for the second dose, the Swedish Health Agency said on Tuesday.Sweden paused the use of the AstraZeneca ...

Read more
20 Apr 2021 00:01

Britain launches expert group to prepare for future pandemics

LONDON, April 20 (Reuters) - Britain on Tuesday said it would launch a new international expert group to help bolster the world's preparedness for the next pandemic and expedite the development of vaccines against future diseases when they emerge...

Read more
19 Apr 2021 22:00

Ontario faces more vaccine delays as it struggles to tame third COVID-19 wave

TORONTO, April 19 (Reuters) - Ontario Premier Doug Ford said on Monday the province expects to face a delay in the supply of AstraZeneca Plc COVID-19 vaccine, dealing another blow to its efforts to contain a punishing third wave of the pandemic."...

Read more
19 Apr 2021 16:57

India hopeful U.S. will soon end curbs on vaccine raw materials export - govt sources

By Rupam Jain and Neha AroraNEW DELHI, April 19 (Reuters) - India is hopeful the United States will soon lift a ban on vaccine raw materials that has threatened to slow output of shots in the country, two Indian government sources told Reuters on...

Read more
19 Apr 2021 14:42

Moderna coronavirus jab rolled out in England, adding to NHS "armoury"

Moderna coronavirus jab rolled out in England, adding to NHS "armoury"

Read more
19 Apr 2021 12:48

EU secures further 100m doses of Pfizer-BioNTech vaccine

(Sharecast News) - The European Union has exercised its option for a further 100m doses of the Pfizer-BioNTech Covid-19 vaccine, the two drug companies confirmed on Monday.

Read more
19 Apr 2021 12:00

Doctors say clot treatment advice key to U.S. resuming J&J COVID vaccines

By Deena BeasleyApril 19 (Reuters) - Resuming the use of Johnson & Johnson's COVID-19 vaccine in the United States will require clear guidelines for the medical community on how to best treat patients that develop a rare type of blood clot, as wel...

Read more
19 Apr 2021 12:00

Doctors say clot treatment advice key to U.S. resuming J&J COVID vaccines

By Deena BeasleyApril 19 (Reuters) - Resuming the use of Johnson & Johnson's COVID-19 vaccine in the United States will require clear guidelines for the medical community on how to best treat patients that develop a rare type of blood clot, as wel...

Read more
19 Apr 2021 11:17

UPDATE 3-India to fund capacity boost at Serum Institute, Bharat Biotech as vaccines run short

* Government clears $610 mln grant to vaccine makers -finmin* Vaccine demand soaring as COVID-19 spreads at record speed (Recasts with India finance minister comment on grants)By Aftab AhmedNEW DELHI, April 19 (Reuters) - India's government has app...

Read more
19 Apr 2021 11:17

UPDATE 2-India to fund capacity boost at Serum Institute as vaccines run short - source

* Serum Institute seeks 30 bln rupee grant from govt* Demand for vaccines rises as cases hit record (Adds context on vaccine exports)By Aftab AhmedNEW DELHI, April 19 (Reuters) - India is set to accept the Serum Institute of India's (SII) request f...

Read more
19 Apr 2021 10:38

India to fund capacity boost at Serum Institute as vaccines run short - source

By Aftab AhmedNEW DELHI, April 19 (Reuters) - India is set to accept the Serum Institute of India's (SII) request for a grant of 30 billion rupees ($400 million) to boost its capacity to make the AstraZeneca COVID-19 vaccine, a government source w...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.